Table 2 General characteristics, mutational spectrum, and amino acid alterations in NRAS
S. No | Patient ID | Mutation | Age | Gender | Tumor location | Tumor stage | Tumor size (cm) | Site of metastasis |
|---|---|---|---|---|---|---|---|---|
1 | SCRC-33 | G10R | 46 | M | Left | 3 | 3.5 | - |
2 | SCRC-3453 | G10R | 40 | M | Right | 3 | 4.0 | - |
3 | SCRC-864 | E37K | 30 | F | Left | 2 | 6.0 | Ovarian/ Liver |
4 | SCRC-198 | E37K | 53 | M | Left | 3 | 4.5 | - |
5 | SCRC-1581 | E37K | 65 | F | Right | 4 | 8.0 | Ovarian |
6 | SCRC-2640 | E37K | 37 | F | Left | 1 | 3.0 | - |
7 | SCRC-2934 | E37K | 81 | M | Rectum | 4 | 5.0 | liver/Bone |
8 | SCRC-1068 | E49R | 33 | M | Left | 3 | 3.6 | liver |
9 | SCRC-1569 | Q61K | 36 | F | Left | 3 | 3.0 | Liver/Lung |
10 | SCRC-4047 | Q61* | 35 | F | Right | 2 | 2.0 | - |